One of the pioneers of CAR T-cell therapy, Dr. Brentjens spoke with Becker's about what the new facility means for cancer innovation, as well as on how leaders across the U.S. can best integrate CAR T ...

Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...

Both consumers and providers have many frustrations with the prescription medication process—the most common are price confusion and potential sticker shock at the pharmacy counter, drug shortages and ...

The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...

Learn about interactions between Nexletol and other medications, supplements, foods, alcohol, and more. You can also find out ...

Authorities shut down over 25 pharmacies in the course of four days as part of a campaign targeting expired or unauthorized ...

This move will help shore up the U.S. pharmaceutical supply chain, which currently relies heavily on foreign sources for key raw ingredients. Also in the news: prescription drug legislation, uses of ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

"It's a sad time when we're making more money off selling a Coca Cola versus a prescription," Tonja Lowery at Elberta ...

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s ...